No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response

No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response

Start complement inhibition (eculizumab/ravulizumab)

Map: TMA (792)
Node: 16365
Score:

OpenLabyrinth is an open source educational pathway system

Review your pathway

Nebulised Salbutamol
Presentation at Accident and Emergency
My INR levels were very high, way above recommended range. My doctor recommended warfarin dose adjustment and close monitor of INR What should I do?
The use of warfarin requires close monitoring of INR.
Πανοραμική ακτινογραφία.
Start complement inhibition (eculizumab/ravulizumab)
No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response

Reminder

FINISH

Time is up